<unk>  is a antineoplastic, immunosuppressive agent that is FDA approved for the treatment of malignant diseases, minimal<unk> hange nephrotic syndrome in pediatric patients.  <unk> ommon adverse reactions include neutropenia, febrile neutropenia, fever, alopecia, nausea, vomiting, and diarrhea.
Cyclophosphamide
Ifosfamide
Mycophenolate
Mafosfamide
Dihydroergocristine
Lenalidomide
Mitoxantrone
Mycophenolate sodium